β‐Blockade with propranolol and hepatic artery blood flow in patients with cirrhosis
- Read more about β‐Blockade with propranolol and hepatic artery blood flow in patients with cirrhosis
Ricardo Mastai, Jaime Bosch, Jordi Bruix, Miguel Navasa, David Kravetz, Juan Rodés – 1 September 1989 – In patients with cirrhosis and portal hypertension, propranolol administration reduces heart rate and cardiac output and diminishes portal pressure and collateral eral blood flow. However, there is little information on the possible effects of propranolol on hepatic artery blood flow. The present study addressed this question in 12 cirrhotic patients with end‐to‐side portacaval shunt, in whom all of the liver blood flow represents the hepatic artery blood flow.